Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 16 |
| Active Pipeline (Recruiting Now) | 5 (5) |
| Completed vs Stopped Early | 7 / 1 (6.3%) |
| Median Closed Actual Enrollment | 201 participants |
| Physical Hospital Site Disclosure | 60.9% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 4 (2 since 2018) |
Explore interactive annual charts and M&A subsidiary rollups in the Glaukos Interactive Dossier, benchmark peers in Ophthalmology and Sensory, or review the Healthcare Price & Patent Cliff Crosswalk.